Novo Nordisk Q3 Wegovy Pill Sales DKK 5.39B; Obesity Sales Up 22% At CER
Share
Why It Matters
Novo Nordisk sold more obesity medicine pills this quarter. Sales grew, which shows people want their new pill form.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.